Exelixis Statistics
Total Valuation
Exelixis has a market cap or net worth of $15.57 billion. The enterprise value is $14.35 billion.
| Market Cap | 15.57B |
| Enterprise Value | 14.35B |
Important Dates
The next confirmed earnings date is Thursday, October 29, 2026, after market close.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 247.78 million shares outstanding. The number of shares has decreased by -6.54% in one year.
| Current Share Class | 247.78M |
| Shares Outstanding | 247.78M |
| Shares Change (YoY) | -6.54% |
| Shares Change (QoQ) | -2.86% |
| Owned by Insiders (%) | 2.63% |
| Owned by Institutions (%) | 95.18% |
| Float | 213.60M |
Valuation Ratios
The trailing PE ratio is 19.72 and the forward PE ratio is 17.93. Exelixis's PEG ratio is 1.61.
| PE Ratio | 19.72 |
| Forward PE | 17.93 |
| PS Ratio | 6.39 |
| Forward PS | 5.78 |
| PB Ratio | 8.48 |
| P/TBV Ratio | 8.75 |
| P/FCF Ratio | 13.28 |
| P/OCF Ratio | 13.16 |
| PEG Ratio | 1.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.06, with an EV/FCF ratio of 12.24.
| EV / Earnings | 16.67 |
| EV / Sales | 5.89 |
| EV / EBITDA | 14.06 |
| EV / EBIT | 14.47 |
| EV / FCF | 12.24 |
Financial Position
The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.46 |
| Quick Ratio | 3.24 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.14 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 44.39% and return on invested capital (ROIC) is 66.00%.
| Return on Equity (ROE) | 44.39% |
| Return on Assets (ROA) | 23.97% |
| Return on Invested Capital (ROIC) | 66.00% |
| Return on Capital Employed (ROCE) | 46.52% |
| Weighted Average Cost of Capital (WACC) | 6.74% |
| Revenue Per Employee | $2.26M |
| Profits Per Employee | $799,093 |
| Employee Count | 1,077 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 3.28 |
Taxes
In the past 12 months, Exelixis has paid $174.84 million in taxes.
| Income Tax | 174.84M |
| Effective Tax Rate | 16.89% |
Stock Price Statistics
The stock price has increased by +59.02% in the last 52 weeks. The beta is 0.47, so Exelixis's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +59.02% |
| 50-Day Moving Average | 56.59 |
| 200-Day Moving Average | 49.76 |
| Relative Strength Index (RSI) | 72.15 |
| Average Volume (20 Days) | 2,400,925 |
Short Selling Information
The latest short interest is 28.18 million, so 11.37% of the outstanding shares have been sold short.
| Short Interest | 28.18M |
| Short Previous Month | 26.40M |
| Short % of Shares Out | 11.37% |
| Short % of Float | 13.19% |
| Short Ratio (days to cover) | 12.71 |
Income Statement
In the last 12 months, Exelixis had revenue of $2.44 billion and earned $860.62 million in profits. Earnings per share was $3.19.
| Revenue | 2.44B |
| Gross Profit | 2.35B |
| Operating Income | 992.02M |
| Pretax Income | 1.04B |
| Net Income | 860.62M |
| EBITDA | 1.02B |
| EBIT | 992.02M |
| Earnings Per Share (EPS) | $3.19 |
Balance Sheet
The company has $839.39 million in cash and $165.93 million in debt, with a net cash position of $1.22 billion or $4.92 per share.
| Cash & Cash Equivalents | 839.39M |
| Total Debt | 165.93M |
| Net Cash | 1.22B |
| Net Cash Per Share | $4.92 |
| Equity (Book Value) | 1.84B |
| Book Value Per Share | 7.41 |
| Working Capital | 888.90M |
Cash Flow
In the last 12 months, operating cash flow was $1.18 billion and capital expenditures -$10.96 million, giving a free cash flow of $1.17 billion.
| Operating Cash Flow | 1.18B |
| Capital Expenditures | -10.96M |
| Depreciation & Amortization | 28.30M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.17B |
| FCF Per Share | $4.73 |
Margins
Gross margin is 96.48%, with operating and profit margins of 40.72% and 35.33%.
| Gross Margin | 96.48% |
| Operating Margin | 40.72% |
| Pretax Margin | 42.51% |
| Profit Margin | 35.33% |
| EBITDA Margin | 41.89% |
| EBIT Margin | 40.72% |
| FCF Margin | 48.13% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 6.54% |
| Shareholder Yield | 6.54% |
| Earnings Yield | 5.53% |
| FCF Yield | 7.53% |
Analyst Forecast
The average price target for Exelixis is $54.87, which is -12.67% lower than the current price. The consensus rating is "Buy".
| Price Target | $54.87 |
| Price Target Difference | -12.67% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (3Y) | 12.63% |
| EPS Growth Forecast (3Y) | 18.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exelixis has an Altman Z-Score of 13.09 and a Piotroski F-Score of 5.
| Altman Z-Score | 13.09 |
| Piotroski F-Score | 5 |